Trial intelligence / Profile preview

Iohexol pharmacokinetics in cirrhotic patients (pilot study)

2018-002778-35Phase 4Completed

Sponsor
CHU de Limoges
Start
Sep 2018
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, open-label, single-arm trial of iohexol, sponsored by CHU de Limoges. Primary endpoint: Plasma and urinary iohexol concentration–time curves. Started Sep 2018; status: completed.

02

Drugs

iohexol

Beyond the preview

Go deeper on 2018-002778-35.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2018-002778-35.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call